Key facts
- This page summarizes FUJIFILM Cellular Dynamics, Inc.'s Form 4 filing for Century Therapeutics, Inc. (IPSC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2021, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Conversion of derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Additional SEC filing notes
Footnote F1
FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.
Footnote F2
FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly.
SEC remarks
Exhibit List: Exhibit 99 - Joint Filer Information